These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12429385)

  • 61. Sortagged anti-EGFR immunoliposomes exhibit increased cytotoxicity on target cells.
    Wöll S; Dickgiesser S; Rasche N; Schiller S; Scherließ R
    Eur J Pharm Biopharm; 2019 Mar; 136():203-212. PubMed ID: 30677497
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
    Nam SM; Kim HS; Ahn WS; Park YS
    Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Targeting of drug loaded immunoliposomes to herpes simplex virus infected corneal cells: an effective means of inhibiting virus replication in vitro.
    Norley SG; Huang L; Rouse BT
    J Immunol; 1986 Jan; 136(2):681-5. PubMed ID: 3001182
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunoliposomal drug-delivery system targeting lectin-like oxidized low-density lipoprotein receptor-1 for carotid plaque lesions in rats.
    Saito A; Shimizu H; Doi Y; Ishida T; Fujimura M; Inoue T; Kiwada H; Tominaga T
    J Neurosurg; 2011 Oct; 115(4):720-7. PubMed ID: 21682565
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of asymmetric immunoliposomal nanoparticles for cellular uptake.
    Whittenton J; Pitchumani R; Thevananther S; Mohanty K
    J Microencapsul; 2013; 30(1):55-63. PubMed ID: 22742513
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Monosynaptic cortical input and local axon collaterals of identified striatonigral neurons. A light and electron microscopic study using the Golgi-peroxidase transport-degeneration procedure.
    Somogyi P; Bolam JP; Smith AD
    J Comp Neurol; 1981 Feb; 195(4):567-84. PubMed ID: 6161949
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antibody-targeted immunoliposomes for cancer treatment.
    Gao J; Chen H; Song H; Su X; Niu F; Li W; Li B; Dai J; Wang H; Guo Y
    Mini Rev Med Chem; 2013 Dec; 13(14):2026-35. PubMed ID: 24251805
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
    Maruyama K; Kennel SJ; Huang L
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5744-8. PubMed ID: 2377612
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antibody targeting of nanoparticles to tumor-specific receptors: immunoliposomes.
    Rothdiener M; Beuttler J; Messerschmidt SK; Kontermann RE
    Methods Mol Biol; 2010; 624():295-308. PubMed ID: 20217604
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs.
    Crosasso P; Brusa P; Dosio F; Arpicco S; Pacchioni D; Schuber F; Cattel L
    J Pharm Sci; 1997 Jul; 86(7):832-9. PubMed ID: 9232525
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A modified protocol for efficient DNA encapsulation into pegylated immunoliposomes (PILs).
    Skjørringe T; Gjetting T; Jensen TG
    J Control Release; 2009 Oct; 139(2):140-5. PubMed ID: 19545595
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Delivery of plasmid DNA to glial cells using pH-sensitive immunoliposomes.
    Holmberg EG; Reuer QR; Geisert EE; Owens JL
    Biochem Biophys Res Commun; 1994 Jun; 201(2):888-93. PubMed ID: 8003028
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Construction and evaluation of pH-sensitive immunoliposomes for enhanced delivery of anticancer drug to ErbB2 over-expressing breast cancer cells.
    Li T; Amari T; Semba K; Yamamoto T; Takeoka S
    Nanomedicine; 2017 Apr; 13(3):1219-1227. PubMed ID: 27965166
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter.
    Zhang Y; Schlachetzki F; Zhang YF; Boado RJ; Pardridge WM
    Hum Gene Ther; 2004 Apr; 15(4):339-50. PubMed ID: 15053859
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunoliposomes for Targeted Delivery of an Antifibrotic Drug.
    Schuster L; Seifert O; Vollmer S; Kontermann RE; Schlosshauer B; Hartmann H
    Mol Pharm; 2015 Sep; 12(9):3146-57. PubMed ID: 26181293
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative studies of the preparation of immunoliposomes with the use of two bifunctional coupling agents and investigation of in vitro immunoliposome-target cell binding by cytofluorometry and electron microscopy.
    Schwendener RA; Trüb T; Schott H; Langhals H; Barth RF; Groscurth P; Hengartner H
    Biochim Biophys Acta; 1990 Jul; 1026(1):69-79. PubMed ID: 2378882
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunoliposomes with different acid sensitivities as probes for the cellular endocytic pathway.
    Collins D; Maxfield F; Huang L
    Biochim Biophys Acta; 1989 Dec; 987(1):47-55. PubMed ID: 2597686
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preparation and characterization of immunoliposomes for targeting of antiviral agents.
    Kalvakolanu DV; Abraham A
    Biotechniques; 1991 Aug; 11(2):218-22, 224-5. PubMed ID: 1931020
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A simple and rapid section embedding technique for sequential light and electron microscopic examination of individually stained central neurons.
    Wilson CJ; Groves PM
    J Neurosci Methods; 1979 Dec; 1(4):383-91. PubMed ID: 397378
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Engineered liposomes to deliver nucleic acid mimics in Escherichia coli.
    Moreira L; Guimarães NM; Pereira S; Santos RS; Loureiro JA; Ferreira RM; Figueiredo C; Pereira MC; Azevedo NF
    J Control Release; 2023 Mar; 355():489-500. PubMed ID: 36775246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.